Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yves Bikorimana: Causes, Diagnosis, and Management of Neonatal Alloimmune Thrombocytopenia
Yves Bikorimana/LinkedIn
Mar 12, 2026, 11:44

Yves Bikorimana: Causes, Diagnosis, and Management of Neonatal Alloimmune Thrombocytopenia

Yves Bikorimana, CEO at MedData-Rwanda and Lab Scientist at The University  Teaching Hospital of Kigali-Chuk, shared a post on LinkedIn:

“Neonatal Alloimmune Thrombocytopenia (NAIT)

Neonatal Alloimmune Thrombocytopenia (NAIT) is a condition in which a newborn develops severe thrombocytopenia (low platelet count) due to the destruction of fetal platelets by maternal antibodies.

1. Definition

NAIT is an immune-mediated disorder where the mother’s immune system produces antibodies against fetal platelet antigens inherited from the father. These antibodies cross the placenta and destroy the baby’s platelets.

  • Leads to low platelet count in the fetus or newborn
  • Similar mechanism to hemolytic disease of the newborn, but it affects platelets instead of red blood cells

2. Cause / Pathophysiology

The main cause is maternal anti-platelet antibodies.

Process:

  • The fetus inherits a platelet antigen from the father that the mother does not have.
  • The mother’s immune system recognizes it as foreign.
  • The mother produces IgG antibodies against this antigen.
  • These antibodies cross the placenta.
  • They bind to fetal platelets and cause their destruction.

Common antigen involved

Human Platelet Antigen‑1a (HPA‑1a)

3. Clinical Features

Newborns may show signs of severe thrombocytopenia, such as:

  • Petechiae (small red spots on skin)
  • Purpura
  • Bruising
  • Bleeding after birth
  • Intracranial hemorrhage in severe cases

Sometimes the baby may appear normal at birth but develop bleeding symptoms later.

4. Major Risks / Complications

Severe platelet destruction can lead to:

  • Intracranial hemorrhage (brain bleeding)
  • Severe internal bleeding
  • Neurological damage
  • Death in severe untreated cases

Intracranial hemorrhage may occur before or shortly after birth.

5. Laboratory Diagnosis

Diagnosis is mainly done through immunological and platelet tests.

Tests include:

  • Platelet count in the newborn (very low)
  • Platelet antibody testing
  • Identification of anti-HPA-1a antibodies
  • Maternal and paternal platelet antigen typing

These tests help confirm the immune incompatibility between mother and fetus.

6. Management

Treatment aims to increase platelet count and prevent bleeding.

During pregnancy

  • Maternal intravenous immunoglobulin (IVIG)
  • Sometimes corticosteroids
  • Careful fetal monitoring

After birth

  • Platelet transfusion (preferably antigen-compatible)
  • IVIG therapy
  • Monitoring for intracranial hemorrhage

7. Key Points

  • NAIT is the most common cause of severe thrombocytopenia in otherwise healthy newborns.
  • Caused by maternal antibodies against fetal platelet antigens.
  • HPA-1a incompatibility is the most common cause.
  • Early diagnosis and treatment prevent life-threatening bleeding.”

Stay updated with Hemostasis Today.

Antibodies Antiplatelet antibodies Blood Fetal platelets Health Hematology Hemostasis Hemostasis News Hemostasis Today HPA-1a IgG Intravenous Immunoglobulin (IVIG) Medicine NAIT Platelet transfusion Yves Bikorimana
NewsFeed